Eclipse Surgical Tech (ESTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eclipse Surgical Tech (ESTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: tuck who wrote (102)	9/14/2000 5:37:47 PM
From: Richard James	of 103

Tuck, Thank U Paine Webber "ESTI Buy, $13 Target, ’00 EPS estimate of ($0.72) and ’01 estimate of ($0.46), Fine tuning second-half forecast for ESTI-expected per share loss for the 3Q has been adjusted to $0.11 from $0.10, but outlook for ESTI’s prospects remains quite favorable, Cannot ignore the fact that ESTI’s leadership position and lucrative annuity stream within a steadily evolving, new market opportunity makes ESTI an extremely attractive acquisition candidate for any one of the larger cardiovascular players." Paine Webber Views, 9-14-00 -Buy, $13 Target -leadership position -lucrative annuity stream -steadily evolving, new market -extremely attractive acquisition candidate Above just posted over on Yahoo. I would also emphasize the language,"ESTI’s prospects remains quite favorable" in discussing the need for a slight downward earnings estimate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext